The global Thymus Cancer Treatment Market is valued at US$ 353.5 million in 2023 and is forecasted to increase at a CAGR of 7.5% to reach US$ 728.7 million by the end of 2033. Thymus cancer, also known as thymoma or thymic carcinoma, is a rare malignancy that originates in the thymus gland, a critical organ of the immune system located in the chest. Although thymus cancer is relatively...